REGN20423, a clinical-stage long-acting IL-13 monoclonal antibody invented and developed by Regeneron, is added to the alliance, along with a long-acting IL-4xIL-13 bispecific and two other ...
Sanofi and Regeneron expand global Alliance with multiple next-generation, long-acting immunology antibodies . REGN20423, a clinical-stage long-acting IL-13 monoclonal antibody in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results